Filed: 11/14/2024ACC: 0001214659-24-019064
📋 What this filing means
TCG CROSSOVER MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 36 equity positions with a total reported market value of $1.18B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
36
Positions
$1.18B
Total AUM (reported)
93.52M
Total Shares
Allocation by class
COMM$984.42M83.4%
ADRS$195.88M16.6%
Portfolio Concentration
Top 3$308.89M26.2%
4–10$380.37M32.2%
11–25$438.79M37.2%
Rest$52.26M4.4%
Top 3 weight
26.2%
Top 10 weight
58.4%
Voting Authority Distribution
Total shares with voting rights: 93.52M
Sole
Full voting authority
93.52M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole36
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings36
Rows:
CG ONCOLOGY, INC.
SOLEShares3.67M
TypeSH
Market value$138.48M
11.73%
Sole
3.67M
Shared
0.00
None
0.00
DYNE THERAPEUTICS, INC
SOLEShares2.65M
TypeSH
Market value$95.19M
8.07%
Sole
2.65M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares6.96M
TypeSH
Market value$75.22M
6.37%
Sole
6.96M
Shared
0.00
None
0.00
Abivax SA
SOLEShares6.06M
TypeSH
Market value$69.77M
5.91%
Sole
6.06M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS, INC.
SOLEShares2.11M
TypeSH
Market value$56.40M
4.78%
Sole
2.11M
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares3.03M
TypeSH
Market value$55.15M
4.67%
Sole
3.03M
Shared
0.00
None
0.00
SAVARA INC.
SOLEShares12.36M
TypeSH
Market value$52.42M
4.44%
Sole
12.36M
Shared
0.00
None
0.00
KEROS THERAPEUTICS, INC.
SOLEShares879.34K
TypeSH
Market value$51.06M
4.33%
Sole
879.34K
Shared
0.00
None
0.00
XENCOR INC
SOLEShares2.43M
TypeSH
Market value$48.81M
4.14%
Sole
2.43M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares1.99M
TypeSH
Market value$46.76M
3.96%
Sole
1.99M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares1.06M
TypeSH
Market value$46.66M
3.95%
Sole
1.06M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX, INC.
SOLEShares5.32M
TypeSH
Market value$46.28M
3.92%
Sole
5.32M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares2.89M
TypeSH
Market value$46.22M
3.92%
Sole
2.89M
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares1.48M
TypeSH
Market value$37.99M
3.22%
Sole
1.48M
Shared
0.00
None
0.00
THIRD HARMONIC BIO INC
SOLEShares2.42M
TypeSH
Market value$32.72M
2.77%
Sole
2.42M
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS, INC.
SOLEShares2.76M
TypeSH
Market value$30.41M
2.58%
Sole
2.76M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS, INC.
SOLEShares2.47M
TypeSH
Market value$29.91M
2.53%
Sole
2.47M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares1.42M
TypeSH
Market value$27.82M
2.36%
Sole
1.42M
Shared
0.00
None
0.00
SOLENO THERAPEUTIVS, INC.
SOLEShares550K
TypeSH
Market value$27.77M
2.35%
Sole
550K
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares3.86M
TypeSH
Market value$24.31M
2.06%
Sole
3.86M
Shared
0.00
None
0.00
Disc Medicine, Inc.
SOLEShares486.96K
TypeSH
Market value$23.93M
2.03%
Sole
486.96K
Shared
0.00
None
0.00
FULCRUM THERAPEUTICS INC
SOLEShares5.25M
TypeSH
Market value$18.74M
1.59%
Sole
5.25M
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares650K
TypeSH
Market value$16.89M
1.43%
Sole
650K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares4.64M
TypeSH
Market value$15.05M
1.27%
Sole
4.64M
Shared
0.00
None
0.00
ADVERUM BIOTECHNOLOGIES, INC.
SOLEShares2.01M
TypeSH
Market value$14.10M
1.19%
Sole
2.01M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY, INC.SOLE | COMM | 3.67M | SH | $138.48M 11.73% | 3.67M | 0.00 | 0.00 |
DYNE THERAPEUTICS, INCSOLE | COMM | 2.65M | SH | $95.19M 8.07% | 2.65M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COMM | 6.96M | SH | $75.22M 6.37% | 6.96M | 0.00 | 0.00 |
Abivax SASOLE | ADRS | 6.06M | SH | $69.77M 5.91% | 6.06M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS, INC.SOLE | COMM | 2.11M | SH | $56.40M 4.78% | 2.11M | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADRS | 3.03M | SH | $55.15M 4.67% | 3.03M | 0.00 | 0.00 |
SAVARA INC.SOLE | COMM | 12.36M | SH | $52.42M 4.44% | 12.36M | 0.00 | 0.00 |
KEROS THERAPEUTICS, INC.SOLE | COMM | 879.34K | SH | $51.06M 4.33% | 879.34K | 0.00 | 0.00 |
XENCOR INCSOLE | COMM | 2.43M | SH | $48.81M 4.14% | 2.43M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COMM | 1.99M | SH | $46.76M 3.96% | 1.99M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | ADRS | 1.06M | SH | $46.66M 3.95% | 1.06M | 0.00 | 0.00 |
OCULAR THERAPEUTIX, INC.SOLE | COMM | 5.32M | SH | $46.28M 3.92% | 5.32M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | COMM | 2.89M | SH | $46.22M 3.92% | 2.89M | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COMM | 1.48M | SH | $37.99M 3.22% | 1.48M | 0.00 | 0.00 |
THIRD HARMONIC BIO INCSOLE | COMM | 2.42M | SH | $32.72M 2.77% | 2.42M | 0.00 | 0.00 |
ASTRIA THERAPEUTICS, INC.SOLE | COMM | 2.76M | SH | $30.41M 2.58% | 2.76M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS, INC.SOLE | COMM | 2.47M | SH | $29.91M 2.53% | 2.47M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COMM | 1.42M | SH | $27.82M 2.36% | 1.42M | 0.00 | 0.00 |
SOLENO THERAPEUTIVS, INC.SOLE | COMM | 550K | SH | $27.77M 2.35% | 550K | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | ADRS | 3.86M | SH | $24.31M 2.06% | 3.86M | 0.00 | 0.00 |
Disc Medicine, Inc.SOLE | COMM | 486.96K | SH | $23.93M 2.03% | 486.96K | 0.00 | 0.00 |
FULCRUM THERAPEUTICS INCSOLE | COMM | 5.25M | SH | $18.74M 1.59% | 5.25M | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COMM | 650K | SH | $16.89M 1.43% | 650K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COMM | 4.64M | SH | $15.05M 1.27% | 4.64M | 0.00 | 0.00 |
ADVERUM BIOTECHNOLOGIES, INC.SOLE | COMM | 2.01M | SH | $14.10M 1.19% | 2.01M | 0.00 | 0.00 |
Page 1 of 2